BACKGROUND
The purpose of this study was to determine the long-term local control, disease-free survival, and morbidity of fractionated high-dose-rate brachytherapy (F-HDR) in infants and children with soft tissue sarcomas.
METHODS
Fifteen children (13 girls and 2 boys, ages 5-101 months) with soft